{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:59:30Z","timestamp":1793325570012,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Foundation for the Development of the Community"},{"name":"MEXT KAKENHI","award":["24K10538"],"award-info":[{"award-number":["24K10538"]}]},{"name":"Progress of the next Cross-ministerial Strategic Innovation Promotion Program on \u201cIntegrated Health Care System\u201d","award":["JPJ012425"],"award-info":[{"award-number":["JPJ012425"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Herpes zoster (HZ) is a global public health concern. Although HZ vaccination is expected to reduce both HZ and its complications, comprehensive epidemiological data to guide vaccination strategies are scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a large-scale analysis of a claims database in Japan to examine standardized incidence rates of HZ and postherpetic neuralgia (PHN) from April 2014 to March 2023. We also evaluated the risks of hospitalization and PHN after HZ, and analyzed varicella incidence using national surveillance data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall standardized incidence rates were 9.58 and 1.00 per 1,000 person-years for HZ and PHN, respectively. From 2014 to 2023, these rates increased, with estimated annual percent changes of 1.16% (95% confidence interval, 0.52\u20132.00) for HZ and 0.99% (0.09\u20133.04) for PHN. The incidence of HZ increased steadily with age: 7.17 in the 40\u201349 age group, 9.73 in the 50\u201359 age group, 13.96 in the 60\u201369 age group, 17.99 in the 70\u201379 age group, and 18.81 in those aged\u2009\u2265\u200980 years. The effect of aging was more pronounced for PHN, with corresponding rates of 0.37, 0.78, 1.78, 2.97, and 2.98, respectively. The overall risks of hospitalization and PHN following HZ were 4.8% and 10.4%, respectively, with risk ratios approximately 2\u20133 times higher in those aged\u2009\u2265\u200970 years than in those aged 50\u201359. HZ incidence was higher in summer and showed little association with varicella incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings provide evidence to inform individuals and policymakers in developing strategies to prevent HZ and its complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12534-0","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T14:33:33Z","timestamp":1768055613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology of herpes zoster and postherpetic neuralgia in Japan: analysis of a large-scale claims database"],"prefix":"10.1186","volume":"26","author":[{"given":"Maho","family":"Adachi-Katayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Sasakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-1695","authenticated-orcid":false,"given":"Shuji","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"12534_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","volume":"32","author":"K Schmader","year":"2001","unstructured":"Schmader K. Herpes Zoster in older adults. Clin Infect Dis. 2001;32:1481\u20136.","journal-title":"Clin Infect Dis"},{"key":"12534_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371:1526\u201333.","journal-title":"N Engl J Med"},{"key":"12534_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-024-01418-7","volume":"16","author":"E Shin","year":"2024","unstructured":"Shin E, Chi SA, Chung TY, Kim HJ, Kim K, Lim DH. The associations of herpes simplex virus and varicella Zoster virus infection with dementia: a nationwide retrospective cohort study. Alzheimers Res Ther. 2024;16:57.","journal-title":"Alzheimers Res Ther"},{"key":"12534_CR4","doi-asserted-by":"publisher","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes Zoster and Long-Term risk of cardiovascular disease. J Am Heart Assoc. 2022;11:e027451.","journal-title":"J Am Heart Assoc"},{"key":"12534_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","volume":"4","author":"SL Thomas","year":"2004","unstructured":"Thomas SL, Hall AJ. What does epidemiology tell Us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26\u201333.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"12534_CR6","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","volume":"224","author":"R Harbecke","year":"2021","unstructured":"Harbecke R, Cohen JI, Oxman MN. Herpes Zoster vaccines. J Infect Dis. 2021;224(Suppl 4):S429\u201342.","journal-title":"J Infect Dis"},{"key":"12534_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/M23-2023","volume":"177","author":"O Zerbo","year":"2024","unstructured":"Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, et al. Effectiveness of Recombinant Zoster vaccine against herpes Zoster in a Real-World setting. Ann Intern Med. 2024;177:189\u201395.","journal-title":"Ann Intern Med"},{"key":"12534_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1248\/bpb.b25-00126","volume":"48","author":"A Shono","year":"2025","unstructured":"Shono A, Hoshi SL, Kondo M. Subsidy programs for herpes Zoster vaccination in Japanese municipalities. Biol Pharm Bull. 2025;48:1185\u201390.","journal-title":"Biol Pharm Bull"},{"key":"12534_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2188\/jea.JE20140210","volume":"25","author":"Y Takao","year":"2015","unstructured":"Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, et al. Incidences of herpes Zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a Community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25:617\u201325.","journal-title":"J Epidemiol"},{"key":"12534_CR10","doi-asserted-by":"publisher","first-page":"ofx007","DOI":"10.1093\/ofid\/ofx007","volume":"4","author":"K Shiraki","year":"2017","unstructured":"Shiraki K, Toyama N, Daikoku T, Yajima M. Miyazaki dermatologist Society. herpes Zoster and recurrent herpes Zoster. Open Forum Infect Dis. 2017;4:ofx007.","journal-title":"Open Forum Infect Dis"},{"key":"12534_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13555-018-0268-8","volume":"9","author":"S Imafuku","year":"2019","unstructured":"Imafuku S, Matsuki T, Mizukami A, Goto Y, de Souza S, Jegou C, et al. Burden of herpes Zoster in the Japanese population with Immunocompromised\/Chronic disease conditions: results from a cohort study claims database from 2005\u20132014. Dermatol Ther (Heidelb). 2019;9:117\u201333.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"12534_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2340\/00015555-0729","volume":"89","author":"JS Jih","year":"2009","unstructured":"Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, et al. Epidemiological features and costs of herpes Zoster in taiwan: a National study 2000 to 2006. Acta Derm Venereol. 2009;89:612\u20136.","journal-title":"Acta Derm Venereol"},{"key":"12534_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.37737\/ace.25006","volume":"7","author":"H Yasunaga","year":"2025","unstructured":"Yasunaga H. DeSC database. Ann Clin Epidemiol. 2025;7:46\u20139.","journal-title":"Ann Clin Epidemiol"},{"key":"12534_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2018.04.004","volume":"77","author":"C Munoz-Quiles","year":"2018","unstructured":"Munoz-Quiles C, Lopez-Lacort M, Orrico-Sanchez A, Diez-Domingo J. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older. J Infect. 2018;77:131\u20136.","journal-title":"J Infect"},{"key":"12534_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes Zoster and post-herpetic neuralgia in italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"key":"12534_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes Zoster and its complications in Germany, 2005\u20132009. J Infect. 2015;70:178\u201386.","journal-title":"J Infect"},{"key":"12534_CR17","volume-title":"Practical guidelines for the management of pain","author":"Japan Society of Pain Clinicians","year":"2023","unstructured":"Japan Society of Pain Clinicians. Practical guidelines for the management of pain. 7th ed. Tokyo (Japan): Bunkodo; 2023. (in Japanese).","edition":"7"},{"key":"12534_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s15010-023-02156-y","volume":"52","author":"M Steinmann","year":"2024","unstructured":"Steinmann M, Lampe D, Grosser J, Schmidt J, Hohoff ML, Fischer A, et al. Risk factors for herpes Zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns. Infection. 2024;52:1009\u201326.","journal-title":"Infection"},{"key":"12534_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40121-023-00902-1","volume":"13","author":"E Sodergren","year":"2024","unstructured":"Sodergren E, Mardberg K, Nishimwe M, Bhavsar A, Marijam A, Bergstrom T, et al. Incidence and burden of herpes Zoster in sweden: A regional Population-Based register study. Infect Dis Ther. 2024;13:121\u201340.","journal-title":"Infect Dis Ther"},{"key":"12534_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ophtha.2022.05.008","volume":"129","author":"Y Sun","year":"2022","unstructured":"Sun Y, Miller DC, Akpandak I, Chen EM, Arnold BF, Acharya NR. Association between immunosuppressive drugs and coronavirus disease 2019 outcomes in patients with noninfectious uveitis in a large US claims database. Ophthalmology. 2022;129:1096\u2013106.","journal-title":"Ophthalmology"},{"key":"12534_CR21","unstructured":"Japan Institute for Health Security. Infectious Diseases Weekly Report (IDWR). https:\/\/www.niid.go.jp\/niid\/ja\/idwr.html. Accessed 13 Sept 2025."},{"key":"12534_CR22","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1016\/j.vaccine.2019.07.086","volume":"37","author":"JK Choi","year":"2019","unstructured":"Choi JK, Park SH, Park S, Cho SY, Lee HJ, Kim SH, et al. The changing epidemiology of herpes Zoster over a decade in South Korea, 2006\u20132015. Vaccine. 2019;37:5153\u201360.","journal-title":"Vaccine"},{"key":"12534_CR23","doi-asserted-by":"publisher","first-page":"2228169","DOI":"10.1080\/21645515.2023.2228169","volume":"19","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Liu X, Suo L, Zhao D, Pan J, Lu L. The incidence of herpes Zoster in china: A meta-analysis and evidence quality assessment. Hum Vaccin Immunother. 2023;19:2228169.","journal-title":"Hum Vaccin Immunother"},{"key":"12534_CR24","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833.","journal-title":"BMJ Open"},{"key":"12534_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/jmv.21599","volume":"81","author":"N Toyama","year":"2009","unstructured":"Toyama N, Shiraki K, Society of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes Zoster and its relationship to varicella in japan: A 10-year survey of 48,388 herpes Zoster cases in Miyazaki Prefecture. J Med Virol. 2009;81:2053\u20138.","journal-title":"J Med Virol"},{"key":"12534_CR26","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/aje\/kwab073","volume":"190","author":"KM Bakker","year":"2021","unstructured":"Bakker KM, Eisenberg MC, Woods R, Martinez ME. Exploring the seasonal drivers of varicella Zoster virus transmission and reactivation. Am J Epidemiol. 2021;190:1814\u201320.","journal-title":"Am J Epidemiol"},{"key":"12534_CR27","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE. The nature of herpes zoster: A Long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9\u201320.","journal-title":"Proc R Soc Med"},{"key":"12534_CR28","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1080\/21645515.2021.1971014","volume":"17","author":"Y Kuniyoshi","year":"2021","unstructured":"Kuniyoshi Y, Tokutake H, Takahashi N, Kamura A, Yasuda S, Tashiro M. Routine varicella vaccination program and hospitalization for herpes Zoster in Japan. Hum Vaccin Immunother. 2021;17:4171\u20136.","journal-title":"Hum Vaccin Immunother"},{"key":"12534_CR29","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annepidem.2005.12.002","volume":"16","author":"W Opstelten","year":"2006","unstructured":"Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16:692\u20135.","journal-title":"Ann Epidemiol"},{"key":"12534_CR30","first-page":"658","volume":"52","author":"S Rowlands","year":"2002","unstructured":"Rowlands S, Moser K. Consultation rates from the general practice research database. Br J Gen Pract. 2002;52:658\u201360.","journal-title":"Br J Gen Pract"},{"key":"12534_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268803001523","volume":"132","author":"DM Fleming","year":"2004","unstructured":"Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect. 2004;132:1\u20135.","journal-title":"Epidemiol Infect"},{"key":"12534_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.4065\/mcp.2011.0724","volume":"86","author":"Yawn","year":"2011","unstructured":"Yawn BP. Post-shingles neuralgia by any definition is painful, but is it PHN? Mayo Clin Proc. 2011;86:1141\u20132.","journal-title":"Mayo Clin Proc"},{"key":"12534_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","volume":"86","author":"M Klompas","year":"2011","unstructured":"Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes Zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc. 2011;86:1146\u201353.","journal-title":"Mayo Clin Proc"},{"key":"12534_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/v13081547","volume":"13","author":"K Shiraki","year":"2021","unstructured":"Shiraki K, Yasumoto S, Toyama N, Fukuda H. Amenamevir, a Helicase-Primase Inhibitor, for the optimal treatment of herpes Zoster. Viruses. 2021;13:1547.","journal-title":"Viruses"},{"key":"12534_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/1346-8138.17364","volume":"51","author":"S Imafuku","year":"2024","unstructured":"Imafuku S, Takeuchi S, Urabe K, Arakawa M, Sasaki R, Oka D, et al. An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes Zoster in patients receiving immunosuppressive drugs. J Dermatol. 2024;51:1279\u201389.","journal-title":"J Dermatol"},{"key":"12534_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.14789\/jmj.JMJ21-0036-OA","volume":"68","author":"Y Kageshima","year":"2022","unstructured":"Kageshima Y, Inada E, Yamaguchi K, Hayashida M. A comparison between effects of amenamevir and Famciclovir on intensities of acute pain and the incidence of postherpetic neuralgia in adult patients with herpes Zoster. Juntendo Iji Zasshi. 2022;68:120\u201330.","journal-title":"Juntendo Iji Zasshi"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12534-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:34:30Z","timestamp":1781627670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12534-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12534"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12534-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Jichi Medical University (approval number: 24\u2013112). The requirement for informed consent was waived due to the retrospective study design and the use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}